The American Patients First Act of 2026 modifies Medicare payment rules for skin substitute products, which are cellular or tissue-based materials used to treat wounds. Beginning January 1, 2027, Medicare will cover these products under a new unified billing code and pay $457 per square centimeter for them through December 31, 2030. The legislation requires that skin substitute products meet strict domestic sourcing requirements, meaning all materials must come from U.S. citizens or permanent residents, and all harvesting, processing, and manufacturing must occur in the United States, though the Secretary can grant temporary waivers during supply shortages. To prevent fraud and misuse, the bill establishes multiple oversight measures including prepayment claim reviews starting January 2027, prior authorization requirements beginning January 2028, and identification of top-spending providers for investigation. The law also restricts payment to only the reasonable portion of products used (at minimum 350 square centimeters or 120 percent of the wound size), limits reimbursement to three applications per wound unless there is improvement, and requires providers to hold certain wound care certifications. The bill allocates $2.5 million annually from 2028 through 2031 for program oversight. Additionally, the Secretary must submit a report by January 1, 2030, analyzing production costs and patient access to these products.

This concurrent resolution honors the 25th anniversary of the September 11, 2001, terrorist attacks that killed 2,977 people in New York, at the Pentagon, and in Shanksville, Pennsylvania. The resolution recognizes the heroism and sacrifice of first responders, including 343 firefighters and 72 law enforcement officers who died in the attacks, as well as the passengers and crew of United Airlines Flight 93 who confronted hijackers to prevent further loss of life. It also acknowledges the ongoing contributions of charitable organizations and nonprofits that have provided support to survivors, families of victims, and first responders over the past quarter century. The resolution encourages Americans to observe the anniversary through remembrance and acts of service while reaffirming the nation's commitment to defending freedom and fighting terrorism. This is a commemorative measure with no funding or implementation requirements, intended to serve as an official statement of congressional recognition and respect.

This resolution expresses the House of Representatives' support for celebrating a "National Day of Honor and Respect" alongside the existing "Constitution Day and Citizenship Day" on September 17. The measure honors the contributions of immigrants and Americans from diverse backgrounds, emphasizing the nation's founding principles of unity expressed through the motto "E Pluribus Unum" (Out of Many, One). The resolution encourages positive interactions among citizens, commits to reducing hate and discrimination, and promotes civic education and public service across communities. It was introduced in June 2026 and reflects on America's history of overcoming divisiveness while marking the 250th anniversary of the Declaration of Independence. This is a non-binding resolution that takes no direct action but signals congressional support for a celebratory observance aimed at promoting national unity and respect for diverse backgrounds.

This bill directs the U.S. Secretary of the Treasury to evaluate China's currency and trade practices whenever a proposal arises to increase China's voting power at the International Monetary Fund. At least seven days before any such proposal is considered, Treasury must report to relevant congressional committees on whether China has maintained transparent exchange rate policies, published credible balance of payments data, avoided currency manipulation to gain trade advantages, and complied with IMF obligations over the prior 12 months. If China fails to meet these standards, the U.S. representative at the IMF must vote to oppose the voting power increase, though the President can waive this requirement by certifying it serves the national interest. This provision would primarily affect U.S. foreign economic policy and America's dealings with the IMF regarding China's influence in the institution, and it would automatically expire seven years after becoming law.

Fraud Prevention and Accountability ActThis bill (1) assigns financial integrity, improper payment prevention, and spending transparency functions to the Bureau of the Fiscal Service (BFS) within the Department of the Treasury; (2) establishes an Office of the Inspector General for Fraud, Accountability, and Recovery (OIGFAR) within Treasury; and (3) requires Treasury to enter into data sharing agreements with other federal agencies and allowable private entities to prevent fraud and improper payments.Functions assigned to BFS by the bill includeadministering the Do Not Pay system (which provides federal agencies and federally funded state-administered programs the ability to verify recipient identity and eligibility before making an award or issuing a payment);maintaining a voluntary governmentwide program to provide data sharing and analysis to federal agencies and to state, local, or tribal governments responsible for administering a federally funded program in order to detect fraud and prevent improper payments that result in financial loss; andsupporting OIGFAR by providing access to information technology and data.The duties of OIGFAR include auditing and investigating the use of certain federal funds, such asfunds, loans, and tax credits made available by various coronavirus response laws;any federal award of $50,000 or more; andemergency spending related to disaster relief or economic recovery.OIGFAR must ensure the expeditious reporting of suspected violations of federal criminal law to the Department of Justice. OIGFAR is authorized to provide investigative support to prosecutive and enforcement authorities to protect program integrity and prevent, detect, and prosecute fraud.

The Fast-tracking Approval for Innovative Rare disease therapies Act would allow certain life-saving medicines approved by trusted international regulators—including the European Medicines Agency, UK Medicines and Healthcare Products Regulatory Agency, and Health Canada—to be automatically approved for use in the United States without going through the full FDA approval process. The bill also permits clinical trials authorized by these same international regulators to proceed in the United States if the drug treats a life-threatening disease. The FDA would have just 30 days to decide whether to grant reciprocal approval and could still withdraw approval if safety concerns emerge or if the international authority rescinds its own approval. Within five years, the FDA must report to Congress on whether the program successfully accelerated patient access to medicines, how many products were approved, and what impact it had on patient safety.

The Stop Identity Fraud and Identity Theft Act of 2026 directs the Treasury Department to establish a grant program providing funding to states for developing digital versions of driver's licenses and identity credentials that meet national security standards. The legislation responds to rising identity theft, data breaches affecting millions of Americans, and billions of dollars in fraudulent transactions—issues the bill attributes partly to weaknesses in current identity verification systems and emerging threats like AI-powered deepfakes. States receiving grants must use at least 10 percent of funds to help residents obtain the credentials needed for digital identity systems, and the bill prohibits states from requiring digital identity use, eliminating physical credentials, or issuing credentials to undocumented immigrants. The Treasury Secretary must establish the grant program within one year of the bill's enactment, though states are not required to participate and the legislation does not specify total funding amounts or program duration.

H.R. 7050, the Homeopathic Drug Product Safety, Quality, and Transparency Act, creates a separate regulatory pathway for homeopathic products that largely exempts them from standard pharmaceutical testing and approval requirements. The bill allows homeopathic manufacturers to make health claims about treating self-limiting conditions based on traditional references or limited clinical evidence (with only an FDA disclaimer required), while protecting them from false advertising liability over the lack of clinical trials. It establishes a 10-member advisory committee dominated by industry representatives, practitioners, and consumers to guide FDA oversight, requires FDA inspector training in homeopathic standards, and shifts the burden of proof to the federal government in enforcement actions. The bill defines homeopathic products as drugs containing only ingredients listed in the Homeopathic Pharmacopoeia of the United States or state formularies, exempting them from typical FDA testing for ingredient identity and strength while requiring compliance with recognized homeopathic safety and quality standards. This legislation primarily affects homeopathic manufacturers, consumers of these products, and FDA regulatory operations, with no specific funding authorization or implementation timeline specified in the sections provided.

The Independence Investment Fund Act establishes a new federal investment fund within the Treasury Department to invest in U.S. companies developing critical technologies—particularly biotechnology—that strengthen national and economic security. The Fund will make seed-to-mid-stage equity investments ranging from $1 million to $10 million per company, targeting companies vulnerable to foreign investment threats and signaling technology priorities to private investors. The Secretary of Treasury will oversee the Fund's strategy in consultation with Defense and Commerce, while an independent managing entity will handle day-to-day operations under supervision of a Treasury-appointed board. The bill authorizes $975.5 million for fiscal year 2025 (including $300 million specifically for biotechnology), plus $22 million annually through 2040 for administrative costs, with potential additional appropriations if the biotechnology reserve drops below $80 million. Annual reports to Congress will track the Fund's progress in meeting national security objectives and complementing other federal technology financing efforts.

District of Columbia Judicial Nominations Reform ActThis bill terminates the District of Columbia (DC) Judicial Nomination Commission. Currently, the commission recommends to the President nominees for judges for DC's Superior Court and Court of Appeals, who must then be confirmed by the Senate. The commission also appoints the chief judges for these courts. The bill terminates the commission's involvement in nominations and requires the President to appoint the chief judges.

The Fairness for Khobar Act of 2025 fixes an eligibility problem that prevented certain victims of two terrorist attacks from receiving compensation they were entitled to. The bill allows victims of the 1983 Beirut barracks bombing and the 1996 Khobar Towers bombing in Saudi Arabia to receive "lump sum catch-up payments"—additional one-time payments to make up for benefits they missed. Previously, these victims were blocked from applying for these extra payments because the Department of Justice had a rule stating that people already receiving regular compensation payments could not also get the lump sum payments, and applicants could only submit one application per claim. Under this bill, the Special Master (the official administering the terrorism victim compensation fund) must develop procedures within 30 days to allow eligible victims to demonstrate they relied on this confusing guidance, then authorize their catch-up payments from reserve funds or the main compensation fund. The legislation essentially corrects what lawmakers view as an unfair restriction that prevented deserving victims from receiving full compensation.

The Words Matter Act of 2025 removes outdated terminology from federal law by replacing the terms "mentally retarded" and "mental retardation" with "intellectual disability" or "intellectual disabilities" throughout the U.S. Code. The bill affects numerous federal programs and services, including Medicare and Medicaid provisions, military family health care, criminal justice programs, nursing facilities, child nutrition programs, and developmental disability services. The changes are purely terminological and are not intended to alter coverage, eligibility, or rights under any affected programs—they simply update language to reflect current medical and respectful terminology. Federal agencies must update their regulations accordingly and clearly note in those regulations that "intellectual disability" was formerly called "mental retardation." The bill does not compel states to change their own state laws, only federal legislation and regulations.

This bill requires federal agencies that administer benefits—such as Social Security, Medicare, housing assistance, food stamps, and unemployment benefits—to provide all public communications in accessible formats for people who are blind or visually impaired. Agencies must offer documents in at least one of four formats: Braille, large print, audio, or accessible digital files like tagged PDFs. These alternative formats must be distributed alongside standard versions through mail or secure electronic systems on the same schedule. The bill protects agencies from legal liability under the Americans with Disabilities Act when they comply with these requirements. The legislation applies to all federal agencies and their contractors, but does not specify any funding or implementation timeline beyond requiring coordination with standard document distribution.

The Websites and Software Applications Accessibility Act of 2025 requires employers, government agencies, and businesses to make their websites and software applications accessible to people with disabilities, clarifying and strengthening requirements under the 1990 Americans with Disabilities Act that courts have inconsistently applied to digital platforms. The law applies to employers, public entities, and public accommodations and defines "accessible" as web content and applications that are perceivable, operable, understandable, and robust—allowing people with disabilities to use them with the same ease and independence as people without disabilities. To support compliance, the bill provides up to $10,000 per small entity in grants over five years to help audit and fix inaccessible digital content, establishes a federal advisory committee with a majority of members with disabilities to guide implementation, and requires the Department of Justice and Equal Employment Opportunity Commission to update accessibility regulations every three years and monitor enforcement through annual and biennial agency reports. The law takes effect six months after enactment, with an additional six-month grace period (12 months total) for covered entities to meet compliance standards, and Congress will fund implementation and enforcement at $35.15 million annually from 2026 through 2035.

Electrodiagnostic Medicine Patient Protection and Fraud Elimination Act of 2025This bill requires, as a condition for Medicare payment, specified electrodiagnostic services to be furnished by qualified facilities that comply with accreditation, training, and other quality control requirements, as established under the bill.Specifically, the bill requires nerve conduction studies and needle electromyography tests to be furnished by facilities that are accredited by an organization that is approved by the Centers for Medicare & Medicaid Services (CMS). The accrediting organization must certify that the facility meets certain standards, including having a quality control program and requiring those who administer needle electromyography tests to have at least three months of specialized training.The bill also establishes an advisory committee to support the CMS in developing appropriate facility standards.

The Health Care Fairness for All Act fundamentally restructures the U.S. health insurance system by largely rolling back Affordable Care Act requirements while preserving seven core consumer protections (no lifetime limits, dependent coverage to age 26, guaranteed availability and renewability, no pre-existing condition exclusions, and non-discrimination protections). The bill introduces new tax credits ($333/month for individuals, $167/month per child) and creates "Roth HSAs"—a new tax-advantaged savings account where contributions are non-deductible but medical distributions are tax-free—while phasing out traditional HSA contributions after December 31, 2025. It grants states broad flexibility to restructure insurance markets outside federal exchanges, including auto-enrollment in high-deductible plans, allows Medicare Advantage plans to fund Roth HSAs and permits "hospital care at home" programs, and makes telehealth flexibilities permanent. The bill also transforms Medicaid into a per-beneficiary quarterly payment system based on historical costs, introduces quality bonuses for top-performing states, allows states to consolidate Medicare and Medicaid for dual-eligible individuals, and strengthens hospital price transparency requirements. Roth HSA provisions take effect January 1, 2026, with Medicaid reforms beginning on a specified implementation date and phasing in over ten years.

Federal Accountability Committee for Transparency Act or the FACT ActThis bill delays termination of the Pandemic Response Accountability Committee until December 31, 2026. (This committee, part of the Council of the Inspectors General on Integrity and Efficiency, was established to promote transparency and support oversight of the coronavirus response and certain coronavirus-related funds.)The bill also renames the committee as the Fraud Prevention and Accountability Committee.

Blind Americans Return to Work Act of 2025This bill requires the Social Security Administration to carry out a demonstration project during which blind Social Security Disability Insurance (SSDI) beneficiaries receive reduced benefits commensurate with income above certain thresholds.Under current law, only individuals who earn under a specified monthly income, known as the substantial gainful activity (SGA) threshold, are considered disabled and thereby eligible for SSDI benefits. For blind workers, this limit is $2,700 per month in 2025. SSDI beneficiaries may earn beyond the SGA threshold for a limited period of time, known as the trial work period, before their benefits are suspended and ultimately terminate.The bill establishes a 20-year demonstration project during which individuals who are entitled to SSDI benefits by reason of blindness and who earn above the SGA threshold continue to receive benefits at an amount gradually reduced commensurate with their earnings beyond a specified amount.During this period, blind workers’ SSDI benefits must be reduced by $1 for every $2 that a worker earns above the sum of (1) the SGA threshold, and (2) the worker’s expenses reasonably attributable to their work. The SGA threshold may not be used to determine whether an individual is disabled during this period, and blind workers’ SSDI benefits may not be terminated due to work-related earnings. The trial work period also must not apply. After 10 years, affected beneficiaries may opt out of the modified benefits structure.

The RED TAPE Act prohibits federal agencies and the Office of Management and Budget from considering non-monetized or unquantified factors when analyzing proposed regulations. This means agencies must base regulatory decisions solely on factors that can be converted into dollar values, restricting their ability to weigh intangible benefits like improved public health, environmental protection, or worker safety unless those benefits are assigned specific monetary estimates. The bill requires agencies to publish detailed summaries and full texts of their cost-benefit analyses in the Federal Register and gives the OMB 90 days to issue updated guidance to ensure compliance. The legislation applies to all rules issued after November 9, 2023, and allows affected parties to sue in federal court to challenge regulations that violate the requirements, with courts authorized to invalidate rules found to rely on non-monetized factors.

Manager Attitudes and Notions According to Government Employee Responses Act or the MANAGER ActThis bill requires federal agencies to conduct an annual survey of managers and make the results publicly available.The survey must include the topics covered by the existing annual employee survey and also specified questions related to employee performance and the disciplinary system. The bill directs the Office of Personnel Management to prescribe standard survey questions to be included in all agencies' surveys. The bill requires agencies to post their survey results on agencies' websites unless the agency head determines that doing so would harm national security.

Securities Enforcement Clarity Act of 2025 or the SEC Act of 2025This bill specifies when separate occurrences of securities law violations must be considered as a single violation for purposes of calculating penalties. Specifically, separate occurrences must be counted as a single violation when the acts in question are the result of (1) a common or a substantially overlapping cause, (2) the same misstatement or omission, or (3) a continuing failure to comply.The bill applies to various violations of securities law, including those involving the registration, offer, and sale of securities; and the conduct of brokers, dealers, and investment advisers.